Global Malaria Technical & Training Support Package (GlobMal) 2024 - 2027


With increased cases and death globally (2019, 2020, 2021) and being off track to meet the Sustainable Development Goals 3.3, malaria is a major global health threat, impacting mainly children under 5 in Sub-Saharan Africa. This burden is exacerbated by new challenges such as increasing resistance to malarial drugs or climate change. The project aims to shape effective global and national malaria capacities and elimination strategies, by providing the necessary scientific evidence and strengthening capacities of malaria-affected countries.

Pays/région Thème Période Budget
Monde entier
Santé
Paludisme
01.01.2024 - 31.12.2027
CHF  1’895’935
Contexte

Thanks to the scale-up of effective malaria vector control tools such as insecticide-treated mosquito nets, diagnostics and medicines, malaria deaths reduced from 897’000 to 568’000 over the period 2000-2019. Despite this progress, there were an estimated 619’000 malaria deaths and 247 million cases globally in 2021. World Health Organization (WHO) global strategy and Roll Back Malaria (RBM) action plan, aligned with the 2016-2030 timeline of the Sustainable Development Goals (SDGs), provide overall strategic direction towards the ambitious 2030 malaria goals to reduce malaria mortality by 40% by 2020 (compared with 2015) and to increase the number of malaria-free countries by additional 10 and 35 countries by 2020 and 2030, respectively.

To support the implementation of these strategies, the malaria control community relies on networks that respond to real-life conditions and translate evidence stemming into practical guidelines and policies. The Roll Back Malaria working groups, managed and led Roll Back Malaria partners such as Swiss Tropical and Public Health Institute, provide a unique multi-stakeholder dialogue platform and are complementary to the technical and small WHO expert groups that have no partnerships with the private sector.

The Global Malaria Technical & Training Support Package (GlobMal), supported by the SDC since 2013, addresses SDG 3.3 of ending the epidemic of malaria and SDG 17 of strengthening global partnerships and bringing stakeholders together to achieve the 2030 targets. It provides support to the global and national malaria control and elimination effort, generates scientific evidence to inform global malaria strategies and helps translate them into country specific action, through global working groups on vector control, case management (malaria treatment) and cross-sectoral action against malaria, and through the training of malaria affected countries’ scientists and national malaria control managers.

GlobMal also brings in Swiss expertise and know-how. The strong role of Switzerland is appreciated, as it is considered a “neutral” agent of knowledge with no political agenda.

Objectifs To contribute to global malaria control and elimination by shaping global and national malaria control and elimination evidence-based policies and ultimately increase the number of malaria free zones.
Groupes cibles

Global malaria community through latest evidence for policy shaping and for advancement of technical expertise.

Malaria control managers from malaria affected countries for capacity building.

Ultimately, populations worldwide of all malaria affected countries.

Effets à moyen terme

Outcome 1: Technical evidence on vector control, case management and multi-sectoral action is generated and communicated in a concerted way via multi-stakeholder platforms (e.g. working groups) promoting country, regional and global exchanges and coordination. 

Outcome 2: Human technical capacities for malaria control and elimination are strengthened in affected countries through a strategically aligned global approach to needs- and competence-based training.

Résultats

Principaux résultats attendus:  

Output 1: The Vector Control Working Group is functional and provides effective support to the global and national malaria vector control efforts in all areas related to coordination and strategies.

Output 2: The Case Management Working Group is functional and provides effective support to the global and national malaria case management efforts in all areas related to coordination and strategies.

Output 3: The Multi-Sectoral Working Group is functional and provides effectives support to the multi-sectoral action in all areas related to coordination and strategies.

Output 4:  Malaria courses for national malaria control managers in various locations are successfully carried out in Tanzania (2025 & 2027), Laos (2026).


Principaux résultats antérieurs:  

GlobMal Phase 1 and 2 have contributed to the emerging global malaria agenda and policies, while Phase 3 has contributed to gather technical evidence on vector control, case management and multi-sectoral action through multi-stakeholder collaboration. Phase 3 has also contributed to building human capacity. The newly established Roll Back Malaria Multi-Sectoral Working Group in phase 3 adopted a new development perspective, extending its focus beyond the health sector (e.g urban policies).

All three Phases ensured direct collaboration with WHO Global Malaria Programme and focused on fostering country ownership and leadership, through three channels: 1. Building human capacity and improving malaria control programs performance at country level through the active participation of National Malaria Control Personnel at the Working Groups annual meetings. 2. Coordinating global networks and helping to spur innovation and shape global policies and guidelines. 3. Strengthening WHO-Global Malaria Programme with technical resources assisting in carrying out its global normative and policy making roles.


Direction/office fédéral responsable DDC
Partenaire de projet Partenaire contractuel
Institution universitaire et de recherche suisse
  • Swiss Tropical and Public Health Institute


Coordination avec d'autres projets et acteurs

Barcelona Institute for Global Health and University of Barcelona (ISGlobal)

Ifakara Health Institute (IHI)

Lao Tropical and Public Health Institute (Lao TPHI)

Budget Phase en cours Budget de la Suisse CHF    1’895’935 Budget suisse déjà attribué CHF    0 Budget y compris partenaires de projet CHF    8’181’935 Projet total depuis la première phase Budget de la Suisse CHF   5’283’865 Budget y compris partenaires de projet CHF   8’000’000
Phases du projet Phase 4 01.01.2024 - 31.12.2027   (Phase en cours) Phase 3 01.07.2019 - 31.12.2023   (Completed) Phase 2 01.07.2016 - 30.06.2019   (Completed) Phase 1 01.07.2013 - 30.06.2016   (Completed)